ABSTRACT. A direct Time-Resolved Fluoroimmunoassay (TR-FIA) system for measuring estradiol-17β (E 2 ) in bovine plasma was developed and evaluated. A 100 µl sample of bovine plasma was used for a TR-FIA without prior extraction and purification. The doseresponse curves of reference standards ranged from 0.0625 to 10 pg/well. The minimum detectable concentration of this assay system was 0.625 pg/ml, and 19 pg/ml of E 2 caused a 50% reduction of maximum binding. The intra-and inter-assay coefficients of variation were 10.2 and 17.4%, respectively. The plasma E 2 concentrations measured by direct TR-FIA correlated closely with those measured after extraction (r=0.939). The results in the present study indicate that the TR-FIA reagent for E 2 , designed for human research can also be utilized, with some modification, for direct assaying in bovine plasma. This assay type seems to fulfill the requirements for safety, sensitivity, specificity, reproducibility and practical convenience. KEY WORDS: direct assay, estradiol-17β, TR-FIA.
Estradiol-17β (E 2 ), one of the most potent estrogens, is produced and secreted by the ovaries and placenta in female animals [3, 4] . Because the E 2 synthesis at the source influences the concentration of E 2 in peripheral blood, a plasma E 2 assay is widely utilized to assess of ovarian and placental functions in human and domestic species [5, 9, 18] . To date, radioimmunoassay (RIA) has been the most commonly used technique. However, in domestic ruminants, extraction and chromatographic purification of plasma samples is required prior to the assay procedure owing to both lower plasma E 2 levels and the limited sensitivity of RIA [13] . Alternative approaches in sample preparation have been tested for bovine plasma E 2 assays using a combination of extraction and defatting to simplify the practice [17] . However, complexity of preliminary processing has not yet been resolved since both methods still require extraction of steroids from plasma.
Because handling radioisotopes entails several potential problems such as radiation hazards and the need for safe disposal, RIA procedures can only be carried out in designated areas. As a routine practice, an assay method should be simple, reliable, sensitive and safe, but RIAs are not. Therefore, a simpler procedure that could be routinely carried out in conventional laboratories to measure plasma E 2 concentrations in the bovine would be of tremendous value.
The enzyme immunoassay (EIA), an alternative approach, has been developed for the plasma E 2 assay [7] . This method uses enzyme-labeled tracer instead of radioactive one in RIA. The EIA is free from radiation, short halflife time of tracer and restriction of handling. Although EIA can compare with RIA in sensitivity, however it still requires extraction of the E 2 from the bovine plasma matrix [7] . Thus to date, non-radiological and direct assay system in bovine plasma E 2 has not yet been established.
Time-resolved fluoroimmunoassay (TR-FIA) employs lanthanide elements as tracers. TR-FIA provides an assay value following time-resolved fluorometry [16] . Since the lanthanide tracer is free from radiological decay, this system has a great advantage over RIA. At present, the reagents for TR-FIA are available for measuring E 2 , but it should be kept in mind that direct plasma immunoassays are sometimes affected by unknown factors present in the plasma. This has resulted in incorrect assay values when compared to the data of extraction assays [15] . The manufacturers of DELFIA TM Estradiol Reagents used in the present study recommend using 25 µl of plasma sample per assay. However, the minimum detectable concentration using this system is 13.6 pg/ ml, which is far greater than plasma E 2 concentrations in cows. Our preliminary studies revealed that 100 µl of bovine plasma interfered with TR-FIA, although this interference factor could be eliminated by an ether extraction of steroids from the plasma matrix prior to the assay. Owing to the complexity of the procedures, extraction assays are considerably more inconvenient than direct assays for routine diagnostic purposes. In the present study, our objective was to establish direct plasma E 2 analysis by using TR-FIA in cows. This paper provides a new technique for simple and sensitive assaying of E 2 in bovine plasma without any prior extraction and purification.
MATERIALS AND METHODS
Animals and blood sampling: Peripheral blood was obtained from Friesian cows for preparing charcoal-treated plasma, and from Japanese Black cows for monitoring the plasma steroid profile. The sampling was done via jugular venipuncture using a heparinized glass tube. The harvested plasma was stored at -20°C until assayed.
Reagents In the present study, standard solution was prepared by ourselves using charcoal-treated bovine plasma and estradiol 17-β (Sigma, St. Louis, MO, U.S.A.).
Direct E 2 assay with TR-FIA: A direct E 2 assay was carried out using DELFIA TM Estradiol Reagent (Wallac, Turku, Finland) with some modifications to the manufacturer's protocol. The assay of all standards and samples was done in duplicate. The plasma sample or standard (100 µl, standards ranging from 0.125 to 10 pg/well), an antibody (100 µl) and assay buffer (100 µl) were dispensed into an assay plate (96-well, precoated with secondary antibody). The stock solutions of the supplied antibody and Eu-tracer were diluted to 1:150 with an Assay Buffer. The standard solution was prepared by adding E 2 (Sigma, St. Louis, MO, U.S.A.) to charcoal-treated plasma (collected from adult Friesian cows). The charcoal treated plasma was prepared as previously reported (15) . The E 2 concentration of the charcoal-treated plasma was confirmed to be below the detectable level of TR-FIA (<1.25 pg/ml). The plate was incubated for 3 hr or overnight at designated temperatures (4, 22 or 30°C), and then washed. A Eu-labeled tracer (100 µl) was added, and the plate was further incubated for 2 hr at the same temperatures as the previous incubation. The plate was washed again and supplemented with Enhancement Solution (200 µl). Fluorescence detection was done using Wallac Fluorometer Model 1234 (Wallac, Turku, Finland) 5 min after enhancement. E 2 assay following extraction: The E 2 extraction was performed with a slight modification as in the previous report [12] . Briefly, 100 µl of distilled water was added to aliquots of plasma (100 µl) prior to diethyl ether extraction. Each sample was extracted by vortex mixing for 1 min with 2 ml of diethyl ether (Wako pure chemical, Osaka, Japan). The two phases were separated, and the aqueous layer was snapfrozen by soaking it in a dry ice-cold ethanol bath. The organic layer was decanted into glass test tubes and evaporated under nitrogen gas. The dried samples were dissolved into 50 µl of assay buffer that was supplied in the kit. This method recovered 109.5 +/-4.0% (mean +/-SEM) of E 2 . Twenty-five µl of reconstituted sample was used for TR-FIA. The extraction assay was done using the same procedure as the direct assay except for the constitution of the standard solution. In the extraction assay, the standard solution was prepared with the assay buffer provided in the kit. The assay sensitivity of the extraction assay was < 25 fg/ well, and 170 fg/well caused a 50% reduction of the maximum binding. The intra-and inter-assay coefficients of variation in extraction assay were 7.4 and 12.0%, respectively.
Progesterone assay: Plasma progesterone (P) concentrations were measured with the TR-FIA kit (DELFIA TM Progesterone Reagent, Wallac, Turku, Finland) as previously reported [15] . All standards and samples were assayed in duplicate. Briefly, a plasma sample or standard (25 µl), an antibody and a Eu-labeled tracer were dispensed into an assay plate (96-well, precoated with secondary antibody). The plate was incubated for 2 hr at room temperature, then washed and supplemented with enhancement solution. Fluorescence detection was performed with a Wallac Fluorometer 5 min after enhancement. The assay sensitivity was < 6 pg/well, and 0.1 ng/well caused a 50% reduction of the maximum binding. The intra-and interassay coefficients of variation were 7.3 and 10.1%, respectively.
RESULTS
Assay standard curves for different incubation protocols are shown in Fig. 1-(A) . Standards and antibody were incubated for 3 hr or overnight at room temperature. After washing, a Eu-labeled tracer was added, and the plates were incubated for an additional 2 hr at the same temperatures as the previous incubation. The curves are comparable between the different incubation periods. The combination of overnight and 2 hr incubations was also used for the following experiment. Figure 1-(B) shows the effect of incubation temperature on the displacement curve of reference standards. The binding count of 0.0625 pg/well, which is thought to be an approximate value of maximum binding, was highest at 22°C. The displacement curve at 22°C was linear from 0.125 to 5.0 pg/well. The binding counts were generally lower at 4°C, although the displacement curve was linear from 0.125 to 1.0 pg /well. During 30°C incubation, the displacement curve undulated in the lowest and highest doses of reference standards (0.125 and 10 pg /well). The 22°C incubation was used for the following experiment. Figure 2 -(A) presents the correlation of displacement curves between the reference standards and the serially diluted mock plasma. The mock plasma was made by adding E 2 into charcoal-treated bovine plasma, and serially diluted up to 16 fold (equivalent to 100 to 6.25 µl of the mock plasma) with charcoal-treated bovine plasma. In the doses tested, the displacement curve of the diluted mock plasma closely paralleled that of the reference standard.
The sensitivity of the assay in terms of the lowest detectable dose of E 2 , which was defined as the value of 2 standard deviations below the zero standard, was 0.0625 pg/well (equivalent to 0.625 pg/ml), and 1.9 pg/well (equivalent to 19 pg/ml) caused a 50% reduction of maximum binding. The intra-and inter-assay coefficients of variation, which determined from 5 replicate assays, were 10.2% and 17.4%, respectively. Figure 2-(B) shows the results of the recovery test. The E 2 (Sigma, St. Louis, MO, U.S.A.) was added to pooled plasma at various concentrations (1.56, 3.13, 6.25, 12.5 and 25 pg/ml). The E 2 concentration of pooled plasma was 5.1 pg/ml. In the tested doses, the average recovery rate was 82.4%. The linear regression formula between the added and assayed values was: Assay value = 0.832 (Added E 2 ) + 5.12 (pg /ml) (r=0.995).
The correlation of the assay values in 14 plasma samples measured by direct and extraction TR-FIA is shown in Fig.  3-(A) . The linear regression formula was: Direct assay = 1.21 [Extraction assay]-0.76 (pg/ml) (r = 0.939). Plasma E 2 and P profiles in estrous cycle is shown in Fig. 3-(B) . The plasma E 2 profile measured by direct TR-FIA was comparable to that of the extraction assay. Plasma E 2 concentrations were increased at a time of luteolysis in both the direct and extraction assays.
DISCUSSION
The RIAs principally involve problems associated with handling radioactive materials. Several approaches have been tried to overcome the problems. The EIA procedure has been developed as one of the most competent substitutes for RIA. This procedure has evolved from the test tube method to the microplate EIA with its great practical convenience. Also in some cases, the sensitivity of some EIA procedures is better than that of RIA [10, 11] . However, the plasma E 2 concentrations in bovine range form 4 to 15 pg/ml [8] , and these values are considerably lower than those of humans and rodents [14] . Due to their limited sensitivities, current RIAs and EIAs require 1 to 2 ml of plasma for assaying E 2 in bovine [1, 7] . Furthermore, it is necessary to extract and purify steroids from plasma matrices prior to the assay procedure. Solving these problems requires a more sensitive assay system with non-radiological procedures. The TR-FIA is an immunoassay with a lanthanidelabeled tracer. It is based on time-resolved fluorometry instead of radiation counting, and is potentially more sensitive than radiation counting [2] . This type of assay has been used for plasma and fecal progesterone analyses in deer [15, 16] . We did several preliminary trials according to the manufacturer's instructions to establish direct assaying for E 2 in bovine plasma. Initially, a reference standard or 100 µl of plasma sample, an antibody and a Eu-tracer were incubated together; the plate was then washed, enhanced and counted. None of these trials was successful, however, owing to the matrix effect of plasma samples. To eliminate the matrix effect, we tried the non-equilibrium incubation method. Namely, we incubated the reference standard or plasma sample and antibody then decanted and washed the plate. After washing the plate was further incubated with Eutracer, washed again and then enhanced prior to counting. This procedure was successful. Using the non-equilibrium incubation method avoids the interference effect of plasma matrices. These results suggest that a large part of the matrix effect in direct TR-FIA is due to the interaction between the Eu-tracer and the plasma matrices. It is likely that the non-equilibrium incubation method is applied to other immunoassays (ELISA or RIA). The plasma E 2 profile measured by direct assay was comparable to that of the extraction assay. Comparing results between the direct and extraction assays reveals direct TR-FIA to be an accurate procedure.
The minimum detectable limit of this assay (0.0625 pg/ well, equivalent to 0.625 pg/ml) is far less than those of reported immunoassays whose lower limits ranged from 0.5 to 10 pg/well [7, 13, 18] . The DELFIA TM Estradiol Reagents, when utilized according to the manufacturer's instructions, have a sensitivity of 0.34 pg/well. Results in the present study indicate that the non-equilibrium incubation procedure improves the sensitivity of the assay system. Since E 2 concentrations in bovine plasma have been reported at above 2 pg/ml, direct TR-FIA has the required sensitivity for plasma E 2 measurement in cows.
The anti-E 2 antibody enclosed in the DELFIA TM Estradiol reagents was highly specific. The cross-reactivities of this antibody to other steroids were 0.75% for estrone, 0.4% for estriol, 0.02% for estrone-3-sulphate and <0.01% for progesterone [6] . With regard to plasma concentrations of these steroids, cross-reactivity is scarcely expected to interfere with the plasma E 2 assay by direct TR-FIA.
In conclusion, results in the present study indicate that the TR-FIA reagent for E 2 , designed for human research can also be utilized, with some modification, for direct assaying in bovine plasma. This assay type seems to fulfill the requirements for safety, sensitivity, specificity, reproducibility and practical convenience.
This study was supported by a Grant-in-Aid from the Ministry of Agriculture, Forestry and Fisheries, Japan.
